Lyophilizate Analytical Services
Coriolis Pharma offers industry-leading lyophilizate analytical services to ensure your freeze-dried drug products’ quality, stability and efficacy. Utilizing our scientific expertise and state-of-the-art technologies, we provide comprehensive lyophilized product characterization that supports your formulation development, lyophilization process optimization and regulatory compliance requirements.
Lyophilizate Analytical Services Tailored to Your Needs
Coriolis offers an in-depth characterization of freeze-dried products throughout lyophilization process development.
Our expert scientists analyze various aspects of lyophilized formulations, including:
- Appearance and structural state of the freeze-dried product
- Reconstitution time and behavior
- Residual moisture in the headspace and freeze-dried product
- Specific surface area
- Glass transition temperature (Tg) of the freeze-dried amorphous product
- Morphology of the freeze-dried product, for example, crystallinity
We take in-process samples throughout the lyophilization process by individual shelf closure to test product characteristics at various stages and obtain samples with different residual moisture content for stability studies.
Our lyophilizate analytical services are carried out under R&D conditions and monitored by our rigorous GRP system. Some of these services can be applied to viruses, cells and viral vectors, and fall under biosafety level 2.
Lyophilizate Analytical Testing Methods
We can select the most suitable approach for your analytical challenge, whether following a standardized in-house workflow or a custom-tailored solution.
Analytical Method Development, Qualification and Validation
For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.
Your Phase
Our expert team has the expertise and experience to guide your biopharmaceutical development program from preclinical and early-phase development to the market.
Lyophilizate Analytics for Your Drug Product
Coriolis Pharma’s deep expertise across many biologic modalities, combined with input from world-leading external advisors, offers the knowledge and experience needed to solve even the most complex formulation and drug development challenges.
Lyophilization Analytical Resources
Publications
December 1, 2023
Publications
November 5, 2023
Publications
January 24, 2023
Publications
Systematic Studies on Stabilization of AAV Vector Formulations by Lyophilization
March 1, 2022